And yes that price says it all. Funny how one’s only argument is why do we hold our shares. Over and over again, even though its been explained the same number of times. Down 70% or so, but still thinks ta is useful. Wrong call after wrong call was made each and every time. Whole board knows it but lives in complete denial. Can’t get past the hatred of us to see reality. Good thing you use the ignore. Saved yourself countless time reading useless posts.

But oddly enough claims ta has stopped them from taking the plunge. I think it’s the factual evidence posted here that’s done it, yet we still get no thanks. LMBO Luckily for them they weren’t around in 2017. Guarantee they would have went all in prior to the raise that killed the price. I’m sure the “ta” would have been a screaming buy at that time.

Think that all you like, but it’s not the case as usual. Here’s another link from the last quarterly that shows it’s NOT the case and again, contract is necessary first. But I guess you’re just thinking management is lying then.

“Assuming we receive a contract from the U.S. government, we expect to initiate an ARS pivotal trial in the second half of 2019.”

https://www.sec.gov/Archives/edgar/data/1158780/000117891319001357/zk1922980.htm

I’ll bet you every single person here that is long in this company, wished they had listened to him. You would have saved a lot cash if you did. Or be able to buy 3 or 4 times the amount of shares with the same amount originally invested. There is no disputing that fact. And yes I’m talking when we used to trade above $2, many moons ago. Many were here touting this stock just as they are doing now. Just like the token analysts have done for so many years.

One of the few who hold those bragging rights, and that can never be taken away.

Yes for sure. Can’t forget about the half page shareholder updates we got a few times as well. No matter how this turns out, they have done shareholders wrong for so many years. An iota of transparency and truthfulness would have gone a long way. Something they have a hard time doing. Could turn this thing into a multi billion dollar company, and I’d still have zero respect for the whole lot of them.

That is a big if, and the million $$$ question. Will find out soon enough.

Lmao. Yes quite the strategy for sure. A decade long one too. But yes seeing this to the end just had to be done. Makes sense to me anyways. No matter what happens, it has been a massive learning experience for me. Adaptive pathways and fast track my ass. Would really hate to see how long it would have taken otherwise. May just be getting to phase 1’s by now. But it is safe to say, the blame in the years of delays falls squarely on the shoulders of our inexperienced management and board.

And one thing for sure. NEVER ever invest in a company that doesn’t do cc’s Just shows they’re hiding something from shareholders.

Those results were for IC trial. CLI is jumping straight from phase one. I think the whole market took the IC results as being inconclusive of anything. Even Pluristem stated the IC results proved their dosage was correct for the CLI trial. Pretty expensive trial to prove that.

But again, I have no idea of the true meaning of the results. The only thing I can go by other than seeing the difference between placebo and treated, is that I know there are people that do. And the large companies that follow biotechs, most certainly have such people. And each and every result we have released has brought about nothing in the way of increasing share price. I’m pretty sure that would not be the case if the results clearly indicated some significant positive results. As many experts have stated, CLI is a tough nut to crack. No guarantees by any means.

I’m talking more about the CLI results. I think the clown club is way over their head in dealing with the government. Well anything for that matter but that’s besides the point. The delay sure poses questions on that point. But it’s no wonder they update nothing on this topic.

Even with CLI, I wonder about the design of the trial and what it will show. We have inexperienced leaders picking whoever it is that designs these things, the CRO, etc. Just look at the phase 2 with IC. The delays and the yawn at the results. But really I don’t know how any of that stuff is done. Just know I’d rather an experienced leader taking us through it all, not a couple of two bit nobody’s from Elbit Vision Systems.

The end is in sight though. Hard to believe a decade has passed. Will it be a final chapter, or a start of something. No way I wouldn’t see this to the end. Here’s to hoping anyways. At least for all the true longs that have suffered in agony over the many years. Don’t think there’s too many here without a different agenda that’s for sure.

Not sure what you mean by INTS. But I truly don’t think we will see increasing positions as we stand now. All that we have seen is pre rs numbers. Don’t imagine tutes wanting to touch any type stock at any point around a rs as the whole world knows how horrible a vast majority of them turn out. If anything I think we will see decreasing positions unless something major happens.

Most definitely. But we will all see what will happen by the 1H20. No doubt they will get the money to survive a few extra months until CLI is out. Then we will see if there was anything to this technology or not. Hoping for the best, but realistically it seems unlikely. But if by some miracle it gets conditional approval, the longs may finally have their day. And if not, the end will have finally come to the Clown Club. Until they move on to the next endeavour.

Just wish they’d do the raise already while price is higher. Enough to make sure they reach that point.

Glad you seem to take joy in misleading others. What a life you must lead, and for those around you to see what you do. Must make them proud.

Yes they owned 5,156,645 as of June 30th. But the main point is they own a tenth of that amount now. I’m sure they loved the rs too. Wonder what their average cost was and how much they are down right now.

Once we see more filings next quarter, we will see what these few larger shareholders have done with their positions.

https://fintel.io/i/ark-investment-management

No it’s not them that’s lying. They have 45 days to file their 13f’s after each quarter. Hence the as of June 30 dates. But I’m quite sure you already know this.

Yes people are holding you accountable for your misleading statements. Not strange. Just long overdue. Just like with the clown club.

Like I said last year when you said September to remember. What year?

Just another point I found regarding pivotal trial for ARS that shows contract must happen first. Wonder what they’re asking for. Can only imagine. Would explain the more than 2 year delay in getting trial stated. And of course, gives them an out from attaining that milestone if/when it doesn’t happen in 2019.

“Assuming we receive a contract from the U.S. government, we expect to initiate an ARS pivotal trial in the second half of 2019.”

https://www.sec.gov/Archives/edgar/data/1158780/000117891319001357/zk1922980.htm

Maybe they’re trying to make up for the CHA agreement. What a deal CHA seems to have gotten. From anything I have seen, it doesn’t look like they have done much. No upfront payment, zero sites in CLI. But they will receive half via the joint company if it gets approved. One million suffering from CLI in South Korea according to the news release. Wonder how much that could potentially be worth. Great negotiating by our inexperienced clown club.

Wonder too how that partnership affected future bargaining with potential partners, since it seems CHA made out like a bandit in that one. Or will if approved. All imo of course since we know little about that deal. But it sure looks horrible to me.

Just like your ARK claim, that’s pre rs numbers there. They had 1.8 mil as of June 30th. But just like ARK, keep your eye out for a 13d filing. Funny ARK hasn’t filed one yet right. And neither will Nikko because they don’t own that many post rs.

That is the only way they could have improved the situation. Honestly can’t see more that a few mil at most. But it would have been detrimental for them selling AND to try and get it above a buck. And the volume post rs does not indicate a substantial amount could have been raised. We will all see in about a month. Unless something comes sooner of course.

But if they got $10 mil or so incognito, that would be great. But not sure how the market will react once that is divulged. In essence, short selling your own stock may not be looked at too kindly.

I accounted for the $18.8 mil they raised if you looked at my numbers right there in paragraph 3 unfortunately And yes the $50 mil open market agreement. That’s the only variable and we will have to wait until September to see. Raised very little via the ATM, and unlikely to be anything of significance from the open market agreement. So again, sitting at around $14 mil left, plus whatever they’ve sold. Tough to make it all the way to April of 2021 like Kaki states.

And if they are selling into the open market, look out for the declines when the company you invest in, acts like a short seller. That’s what people look for in well run companies. Should help in attaining another raise too.

In essence you are sorry. They just totally shafted the “investors” from the raise in April of this year. Down approximately 20% since they went in. That’s a combined loss of $4 mil of the $20 mil invested. Don’t even want to go into the Israeli investors from the second raise of 2017. They’ve been bludgeoned. What was that done at, $1.70.

I would love to see a huge uptick in tutes. It’s dismal as we stand now. I wish ARK or someone would take a huge position. Putting a board member on there would most likely have to occur. Nobody at Pluristem wants that though. Don’t think they’ll be lining up though after the RS. They know the severe risks associated with a company that does it. At least a company like ours for sure.

So approximately $14 mil in cash left is where we stand today. Not much when your burns around $9 mil before the big “streamlining” of operations that just occurred.

Absurdity in every sense of the word. Shown factual evidence of how the clown club falsely makes everything out to be ok. Just the two statements Kaki stated from those two reports. Had enough cash to last until around June of 2020 as they stated back in March of 2018. But then do a raise of $20 mil in April of 2019. Something stinks. Numbers just don’t add up.

Or how about Kaki’s “other resources” when trying to bulk up the piddly amount of cash they had a while back. Jokes all around. But who cares about the financial situation. We can just get more and more via dilution. Not many stocks sitting at the number of shares we are at. Quite funny to read actually. But all of that’s in the past. We only look forward now. Jokes.

They need cash to survive. A pretty important topic if they want to make it to a year from now. As it stands now, they can’t without enabling the cash contingency plan. Yes they will most likely need to do a painful raise for the second time this year if nothing else comes to fruition very soon. That will have a significant impact on our price in the coming months. Ignore that fact and see what happens if you like.

We know they are in 2 phase 3’s. That’s not the point. It’s the funding in question. Management stated this in their last quarterly. Correct me if I’m wrong, but the following means April 1st 2021? Zero chance of that happening.

And strangely enough look at what they stated March of 2018 as well. Enough to last until sometime between April and June of 2020. Why did they have to do the raise if they had enough to last. But they did do the raise for $20 mil since then, but have squeezed out 3 more quarters of survivability. A burn rate of just under $10 mil per quarter, somethings not adding up. Believing what management states is accurate, is a recipe for disaster.

And at the bottom I’ve posted numbers according to their last quarterly. Feel free to pick it apart once again. All factual numbers that can’t be fudged.

As of March 30, 2019.

“According to management estimates, liquidity resources as of March 31, 2019, together with the funds received from the public offering and registered direct offering that closed on April 8, 2019 (see Note 8), will be sufficient to maintain the Company's operations into the beginning of the fourth quarter of the Company's fiscal year 2020. The Company's inability to raise funds to carry out its business plan will have a severe negative impact on its ability to remain a viable company.”

https://www.sec.gov/Archives/edgar/data/1158780/000117891319000311/zk1922533.htm
 
As of March 2018

“According to management estimates, liquidity resources as of March 31, 2018, will be sufficient to maintain the Company's operations into the first quarter of the Company's fiscal year 2020. The Company's inability to raise funds to carry out its business plan will have a severe negative impact on its ability to remain a viable company.”

https://www.sec.gov/Archives/edgar/data/1158780/000117891318001552/zk1821599.htm


Here again is my take on their financials taking from their last filing. Please look at it carefully and tell me how they will make it to trial results without additional funding. Let alone, to 2021.

As of March 31st 2019 they had approx $13 mil in assets, minus $8 mil in current liabilities. (I know they don’t have to be paid immediately, but they need to be paid).

So that left them with $5 million big ones. Now they did do a raise in which they raised approx $20 mil and paid a 6.5% fee, bringing net of $18.8 mil to Pluristem.

So a grand total of approximately $$23.8 mil left. Now what was their burn rate in the last quarter. $9 million. We have had a quarter and a third go by now, so take away $10 mil approximately.

So we sit with approximately $14 mil left in the bank. Even if they reduce the burn down a couple mil to $7 million, we are 6 months away from running out of cash.

We only know the status on one of them. Hip we have no idea. No half way mark announced there. They need 240 patients to go through that one with a year follow up. Don’t recall ever seeing a half way point mentioned for interim results. Full enrolment needed before results.

Options are limited, and shameful they have let it get to this point yet again. Two raises in 2017 along with the ATM, and one in 2019 with a real possibility of another. Mismanaging their funds has been happening from day one, and continues to this day. 25 percent cut in management salaries and still having 170 employees is proof of that.

How has Brainstorm managed with a fraction of the number of employees and spending $14 mil for the year 2018. They are deep into phase 3 for ALS, and in phase 1/2 for MS.

They have more than enough cash to see them through their phase 3 at least. Too bad our management wasn’t as frugal as theirs. CEO may not have pharma experience, but was wise enough to bring in executives with vast pharma experience. That’s what great leaders do. We unfortunately didn’t do neither and still don’t.

Yes the cash on hand is a huge problem at the moment. I’d imagine a raise will be attempted soon while the price is higher due only to the rs. Who would invest I don’t know. But a big discount and warrants would definitely be required. We may see to if any patients have been enrolled in the expanded access and how much revenue was generated if anyone has gone through it. May buy a little more time as well if any decent numbers have gone through that way. Wouldn’t count on that too much though. But half way went relatively quickly so you never know. We will know in a month the severity of the situation and if any revenues were generated that way.

A government contract based on pivotal trial results will buy nothing in terms of their cash situation. Need the cash very soon and half a year or a year out won’t cut it.

Could also see something via Chart or Thermo, but don’t see anything significant there in the near term. Especially with Chart. Supposed to hear about them too, but no timeframe attached to them so no idea when.

If they do the raise, we could assume contract is not happening any time soon. One way or another, I’m sure they’ll figure out how to survive until the CLI interim data is released. That data would have to be great, with statistical significance. It was the 3 year follow up time that allowed them to have so have low enrolment numbers in the trial. We will only see follow up of one year only. Delays to see additional data would or extended follow up time could be the final nail. Or bad results which is a definetetpossibility going straight to phase 3 from 1.

What gets brought up is not part of the distant past only. Every release they make has zero guidance, zero transparency and filled with ambiguity. The recent raise, the RS, both just happened. Why? Because they waste money like nobody else. They built this company up like they were close to approval many years ago, and have blown through a quarter billion dollars because of that huge mistake.

The brilliant quote from Kaki stating because of the streamlining of their business, they will have the same amount of cash when they get results was last month. An impossible statement to achieve. And trying to make the excuse that Lonza spent $25 mil on stem cells from Lonza manufacturing. We have needed what, one bioreactor running to produce all the cells we have ever needed. But we built a 500 square meter clean room to do it for what?

They’re paying dearly for those gaffs dearly now, and so are we as a result. But yes everything they have done is the past, and all should be forgiven as we trade near our decade lows. I’m sure Pluristems board will think their next round of bonuses should be huge again like they did back in 2016. They’re all sitting with under 500k shares now again. Totally unacceptable for all the wealth thever created for shareholders. Little premature on that bonus as well.

One more time I will try to explain why I am still here. Been in it for over a decade now. Not going to have zero skin in the game when the end is so near, one way or another.

We have been told about two upcoming expectations. Government contract and pivotal trial to happen in 2019, and interim results from CLI in 1h2020.

Options were a cheap way to use leverage if something big was to happen. The amount I have lost as they expire, wouldn’t have been a big position at all if I had bought shares instead. And that position would have been down 70% or more as well.

We are in another downward slide. If we get no contact or pivotal trial by the end of the year, the decline will get much worse. If by chance we get some sort of significant contract which seems unlikely to me, would move this stock and I will be rewarded greatly.

Or if/when they do another raise will have the same effect. That will again allow me to buy cheaper options at a cheaper price. And that will put it passed the timeline of expected CLI results.

I was surprised they made it to half enrolled when they did. That may be the only thing that they have accomplished with any sort of speed. So those results should come out on time, or with some delay but not years.

Good results with conditional approval would certainly see this thing move and again reward me significantly. Poor or inconclusive results will stick a fork in this pig, and will put them out of business imo. Or make it near impossible to survive without an even bigger miracle.

Like I said the end is near to finding out how this will play out. Hopefully this will put an end to the daily questioning of why I am here. Judging on PAST experience, I doubt it.

It’s funny too as to why some have decided not to go all in. Many questions plague this company. Going all in would have brought about a significant loss if they did. What else was it that put doubt in their mind? You’re welcome.

What about the cha agreement from way back in 2013? Have we heard a single thing about them since that was signed? Here’s a couple of things from that release.

“Under the terms of the agreement, Cha will perform and fund multiple clinical trials in South Korea for treating CLI and IC using PLX-PAD under the supervision of the Korea Food & Drug Administration (KFDA)”

“While Cha will bear the costs of conducting the clinical trials for the agreed upon indications, Pluristem will continue to retain rights to its proprietary manufacturing technology and cell-related intellectual property.”

I wonder how much they have actually spent on either indication. There are zero South Korean sites in the ongoing CLI trial. They had 8 out of 34 sites for the IC trial. That’s all that we know about this “agreement”

We have no idea what this inexperienced team negotiated in this contract, as we can’t see it. Sure doesn’t seem like CHA has “beared the cost” of these trials. Seems to me Pluristem and it’s inexperienced team, was out negotiated by a pharma company. Go figure. But what else would you expect.

Just another example of the ambiguity of their releases, and zero transparency as to what is going on with this partnership like pretty much anything else this company is involved in.

To not look at their past is a fatal mistake. When you look at a resume, do you look at forward looking aspects in a persons career, or do you look at the past to see if what they have done warrants hiring them. It’s the only way you can see what you think they might bring to the company.

This is taken from their latest quarterly. So no, it’s just still in limbo. Expedited Japanese approval process my ass. You can think what I say is false, but sadly it’s not.

“the proposed joint venture to be established with Sosei Corporate Venture Capital Ltd. for the clinical development and commercialization of Pluristem’s PLX-PAD cell therapy product in Japan, the plan to enter into definitive agreements and the timing of entering such agreements;”

When management tells you they should be getting a contract in 2017 and still haven’t two years later, I don’t know what you’d call it.

When management tells you 2018 will be the year of the shareholder and then you just get substantial losses, I don’t know what you’d call it.

When management says pivotal ARS trial will begin in 2017 and it hasn’t still to this date, I don’t know what you’d call it.

When management tells you a partnership will be formed with Sosei, then delay it, make an excuse how complicated it is, then never bring it up again for a couple of years, I don’t know what you’d call it.

When management forms a binding term sheet with a Chinese entity, then states it failed because of fictitious reasons, I don’t know what you’d call it. Remember an article that said the potential partner didn’t like what they saw after they did their DD.

There are endless examples of being misled. Maybe if we had experienced management, they would KNOW how long things take. Wouldn’t be building and maintaining a manufacturing facility 10 years too soon. Quarter of a billion dollars. Astonishing they have blown through that much and are still a long way from any finish line.

What do you think throwing 10 million shares at the market would do to the price. This drop is all because of the clowns running this thing. Throwing a quarter of those shares into the market would decimate the price. And that’s what all investors are hoping, for the company they’re in to be acting as a short seller. And dilute at the same time. Yes the money is needed, but sadly no matter how much they have raised over the last decade, it’s ALWAYS an issue.

Thank you Electrify. I have explained to them over and over my reasoning but they choose to ignore. I have been in this for a decade as well. Far too long to not see it to the end. Imagine I didn’t and they actually came through with something. I’d be pissed. The likelihood of that happening dwindles with each passing quarter. We will see soon enough if they can pull off a contract this year. Just hope it’s not for $10 mil. But hey, that would be huge for these goons.

I was, still am, a believer in the technology, not management. We have just blown through a quarter of a billion dollars because of who runs this thing. Yes I can go overboard on what I call these guys, but imo it is well deserved. They have misled shareholders for years, and have zero transparency. Not a single CC ever. True cowards for not facing shareholders. Anyone who thinks these clowns are good have a different agenda than I do. Nobody in a real company would be able to keep their jobs after the performance we have seen for the last decade. Unfortunately the entire board seems to be working for management, not shareholders like they’re supposed to. Go figure. Can’t wait to see how many gifted shares they get next year, if we make it that far.

That’s what I’m thinking. Remember someone was posting here that their son was an accountant and was going to prove my numbers wrong. Never heard back on that one did we. So many false statements made here it’s ridiculous. Don’t know why I spend so much time shooting them down, only to have some not see it no matter how many links I provide that prove otherwise. But it is kinda fun showing how foolish their statements can be.

Not quite sure how I can get anything more recent than their last quarterly where I got the numbers from. Or the piddly amount they raised via the ATM in the 9 months previous. About $49 mil shy from what some think. But we will see in the next month what their latest figures are. And we will be 2 months lower in cash on top of it when that gets released. Fingers crossed that we have 6 quarters of cash left. Pretty ridiculous statement to make.

But have a look at the following quote from our CEO. Pretty astonishing that due to the streamlining, they will have the same amount of cash when the trials are complete as they have now. How is that even possible? Everyone working for free? People doing trials free of charge? Shows what a complete moron our leader is. Crappy accountant too.

"Following our streamlining, we'll reach results in the two trials with the same amount of cash we have now."

And here’s another thing that I have been mentioning for a couple of years. Not only did they build it prematurely, they even expanded it. So wasteful it’s not funny. But again, idiot is their middle name. No experience gets you to hovering around decade lows. But yes, continue to be ok with them.

Pluristem has a plant founded early in the decade, although it not yet marketing products commercially. The plant consumes resources and requires personnel, which is one of the factors for the company's relatively high burn rate.

https://en.globes.co.il/en/article-pluristems-new-ceo-explains-why-share-fell-80-1001292053

It’s based on their last quarterly. How do you keep coming back with nothing. Seriously do some dd before you post. Six quarters of cash left. That’s hilarious.

You’re wrong sorry. I already went through their cash situation. Look back as you may become informed for a change. Just over 2 quarters left. Nobody seemed to question it when I posted it. They did previously when they were in a dire situation. Then when the quarter came out I was pretty close. Of course we will have to wait to see if they sold any during the last quarter via the ATM. Doubt it will be much of anything at all. But the Clown Club wants their paycheques so you never know.

It would seem your trying to help the weed stocks with their revenues.

And how many did they sell the 9 months ended March ‘19. I gave you the answer. You choose not to look for some reason. But in another month, you’ll see all the “block trades” they made. Be surprised if they used it at all.

Like the other one, resort to personal attacks when you’re proven wrong. Stick to the weed stocks. You’re probably in there at the right time as there’s no big players there. Penny stocks will prevail in that space.

You read the info yourself. I gave you the help. SEC website. Lots of big numbers there. Use it if you wish or go around wrongly thinking they got $50 mil and can last until the end of 2020. Don’t be too shocked when a raise is done soon.

You should really do some DD before you post stuff. That’s the ATM agreement not a $50 mil raise. Not an ATM where you get cash from a bamk machine. Although I think the Clown Club thinks it’s that too. And that’s what everyone wants, the company acting as a short seller into any mini run we get. Not that they’ve used the ATM much. Taken from a thing called the sec site. Should check it out sometime.

“During the nine month period ended March 31, 2019, the Company sold 1,706,000 shares of common stock under the ATM Agreement at an average price of $1.23 per share for aggregate net proceeds of approximately $1,952, net of issuance expenses of $148.”

So they’re still a wee bit short still. Keep trying though.

Sorry but this stock is a shorters dream. With the rs of course the shorts will come back in full force. No controller necessary when a Clown Club runs a company.

No nerve at all sorry. Am I writing in CAPS? LMBO. I know what’s in store and the gamble I take. Some should be so lucky in this pig. Too deep after buying more at every new bargain year after year.

I would really like it if you could show me where I said the trials have failed or they are dead. I said missed. Meaning the company put out a timeframe and didn’t achieve it, or are still waiting to. Pretty simple factual statement so I’m dumbfounded that you can’t grasp the difference. Just keep deflecting and distracting. Some have a tendency to do that when there’s no gas in the tank.

Much of it is repetitive yes. You want to question things over and over, even though I have shown you evidence directly from Pluristem to prove them. That’s why your arguments are weak in every aspect. Also, newbies like Vinny come here like they have some secret information trying to spread false things. A weed player coming out because we got cannabinoids in a press release. Trying to pump a quick buck without knowing the clown club that makes it impossible to do so. Learnt the hard way I guess. Or others spreading false claims that have been here forever. So arguments have to be brought up again and again to dispel the garbage posted here.

Again, should have listened to us. Remember the could go up to the $1.50’s post when you were in full form. Didn’t pan out there did it. But judging by the stocks you’ve been in, you’re a glutton for punishment. To each their own.